Healthcare Outcomes Performance Company HOPCo Acquires Dutch Startup Caro Health

The deal expands HOPCo’s presence in Europe and advances its mission to build a global, AI-powered care delivery platform.

“Our partnership with HOPCo enables us to accelerate our technology, expand our reach, and deliver intelligent, personalised healthcare communication on a global scale – faster and more effectively than ever before,” said Thomas Goijarts, Co-founder and CEO of Caro Health.

“It will also allow us to better serve our local customers here in the Netherlands and across Europe by leveraging HOPCo’s clinical expertise and comprehensive digital platform and services. This will help us stay focused on our core strengths while speeding up the development of patient-centric, value-based technology solutions. We’re excited to be part of the HOPCo Digital Health Team as we work to replicate the success we’ve achieved in Europe, in the United States,” he added.

Founded in 2019, Caro Health developed a proprietary AI system that delivers personalized, scalable communication for patients and providers. Serving nearly 40 healthcare organizations across the Netherlands and Belgium, its platform supports various clinical specialties—including orthopaedics and MSK subspecialties—and integrates smoothly with electronic health record (EHR) systems to streamline workflows and reduce administrative tasks.

Read Also - UK-based Nokken Receives Investment From Limestone Capital

After the acquisition, Caro co-founder Goijarts will become Head of Products for HOPCo Digital, reporting to the Global Chief Information Officer. Co-founder Guusje van der Heijden will lead customer success and delivery in Europe, focusing on expanding HOPCo’s reach and enhancing digital platform services for clients.

HOPCo plans to grow its European office by adding staff to support international expansion and strengthen healthcare provider partnerships worldwide.

Caro’s platform and team will join HOPCo’s Digital Health Division, contributing to AI improvements for products like HOPCo Vitals, myrecovery by HOPCo, HOPCo’s EMR Ecosystem, and its cloud infrastructure serving practices, ambulatory surgery centers, and health systems.

“We have been hugely impressed with Caro’s thoughtful approach to integrating Conversational AI into complex clinical workflows,” said Dr Tom Harte, President of HOPCo Digital. “The Caro team has clearly demonstrated that, when partnering with physicians to combine best-in-class technology with deep clinical expertise, Conversational and Generative AI can enhance both patient experience and operational workflow. This enables both physicians and administrators to focus on delivering patient care.”

With digital health partnerships across the US, UK, Australia and Europe, HOPCo provides turn-key value-based care programs designed to improve patient outcomes and reduce costs. Integrating Caro’s technology is expected to boost these efforts, delivering clear benefits for patients and healthcare providers worldwide.

“At HOPCo, we are building the most comprehensive digital platform globally with end-to-end products and services necessary to support practices, ambulatory surgery centers, health systems, and payors – from patient management to top-tier Cloud-based security,” said Chris Martinez, Global Chief Information Officer at HOPCo.

“The integration of Caro Health’s innovative technology across our full suite of digital products and services will accelerate our AI roadmap and enable us to better support our customers across the globe in delivering high-quality, cost-effective care. Our time-to-value is crucial to our overall success, and we will continue to make strategic acquisitions, develop new products, and hire world-class engineering talent,” he added.

About HOPCo

HOPCo leads in musculoskeletal value-based care, managing specialties like orthopedics, spine, and rehabilitation. Its integrated platform improves patient care and revenue while reducing costs. Partnering with payors and health systems, HOPCo enables efficient risk-based contracts through proprietary analytics and standardized care, driving sustainable population health success.